AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Halozyme Therapeutics, Inc.
$128.95
+$58.64 (+83.40%)
Previous Close
$130.91
Day Range
$127.52$131.89
Year Range
$61.23$134.00
Market Cap
14.64B
AVG Volume
2.16M
Trailing/Forward PE
36.63/12.39
PEG ratio
1.17
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQ
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Earnings: HALO
Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 5 Nov 2026.
Video analysis: HALO
All videosNo video analysis for this stock yet. Request one from our team.
